Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Differentiation-inducing retinoid-related compounds disclosed by Eisai

March 18, 1997

OXiGENE reports favorable preclinical results with Neu-Sensamide and Oxi-104

March 17, 1997

Anticancer agent from Banyu heading for clinic

March 14, 1997

Protein tyrosine kinase inhibitors from Glaxo Wellcome

March 14, 1997

Initial clinical results with LGD-1069

March 14, 1997

Pharmacopeia achieves milestone in collaboration with Schering-Plough

March 13, 1997

Matrix's radiation enhancer enters phase I/II

March 13, 1997

Antiestrogenics from Schering AG

March 13, 1997

U.S. patent for Sugen's lead cancer therapeutic

March 12, 1997

Pharmacyclic earns NCI support for anticancer compounds

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...